Vertex

News

New Vertex drugs could help 90% of cystic fibrosis patients

Vertex soars after news that tens of thousands of cystic fibrosis (CF) patients could benefit from treatment for the first time.

News

AZ's asthma drug Fasenra approved in EU

A further 3,400 children are eligible for treatment with Orkambi

News

Promise of CF combinations lifts Vertex, reignites takeover ...

Encouraging results from three pipeline combination therapies suggests Vertex could extend treatment to patients with more severe and difficult to treat cystic fibrosis.

News

FDA chief nominee Gottlieb reveals industry links

Scott Gottlieb, president Donald Trump’s nomination for FDA commissioner has revealed his close links with pharma.

News

New NICE rules could deny drugs to rare disease patients

Patients could be denied treatments, says BIA

News

Outlook bright for Vertex despite European delays

But analysts excited by promise of next generation of medicines.

New Vertex drugs could help 90% of cystic fibrosis patients

AZ's asthma drug Fasenra approved in EU

Promise of CF combinations lifts Vertex, reignites takeover ...

FDA chief nominee Gottlieb reveals industry links

New NICE rules could deny drugs to rare disease patients

Outlook bright for Vertex despite European delays

Senju launches first-in-class dry eye disease drug in Japan

Using AI-driven synthetic personas to take your insights fur...

Vertex

Editor's Picks